Evidence map›Paper›PMID 32775268›Full record

ArticleGland surgery2020

Breast-conserving therapy is safe both within

Xin Huang, Xiu-Yu Cai, Jia-Qi Liu, Wen-Wen Hao, Yi-Dong Zhou, Xiang Wang, Ying Xu, Chang Chen, Yan Lin, Chang-Jun Wang and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Gland surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 3 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 3 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Xin HuangDepartments of Breast Surgery, Peking Union Medical College Hospital, Xicheng District, Beijing, China.
Xiu-Yu CaiDepartment of VIP Region, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Jia-Qi LiuDepartment of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wen-Wen HaoSun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Yi-Dong ZhouDepartments of Breast Surgery, Peking Union Medical College Hospital, Xicheng District, Beijing, China.
Xiang WangDepartment of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Ying XuDepartments of Breast Surgery, Peking Union Medical College Hospital, Xicheng District, Beijing, China.
Chang ChenDepartments of Breast Surgery, Peking Union Medical College Hospital, Xicheng District, Beijing, China.
Yan LinDepartments of Breast Surgery, Peking Union Medical College Hospital, Xicheng District, Beijing, China.
Chang-Jun WangDepartments of Breast Surgery, Peking Union Medical College Hospital, Xicheng District, Beijing, China.
Yu SongDepartments of Breast Surgery, Peking Union Medical College Hospital, Xicheng District, Beijing, China.
Qiang SunDepartments of Breast Surgery, Peking Union Medical College Hospital, Xicheng District, Beijing, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNPeking Union Medical College Hospital · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

methodsThe study comprised a cohort of women with invasive breast cancer either receiving BCT or mastectomy following the criteria for the germline

resultsIn

conclusionsThus, BCT may be a safe and rational choice for Chinese female breast cancer patients with a

Indexed as

BRCA1/2 mutationbreast cancerBreast-conserving therapy (BCT)mastectomyprognosis

Identifiers

PMID32775268
PMCPMC7347799
OpenAlexW3037426265

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.